Medigate

Medigate developed a purpose-built security platform for healthcare environments that discovers, classifies, and monitors connected medical devices (infusion pumps, imaging systems, patient monitors, ventilators, surgical robots, dialysis machines, etc.) and clinical IoT assets across hospital networks. The platform used deep packet inspection, device fingerprinting, and clinical workflow context to identify devices, assess their risk posture, detect anomalous behavior, and enforce network segmentation policies without disrupting patient care operations. This is critical because modern hospitals operate with thousands of connected devices running legacy protocols and embedded systems that lack native security controls.

The healthcare IoT security market addresses a fundamental vulnerability: connected medical devices were often deployed with minimal security-by-design, relying on network perimeter defenses that are no longer adequate in modern threat environments. Hospitals face pressure from ransomware campaigns, insider threats, and sophisticated nation-state actors targeting healthcare infrastructure. Medigate's differentiation centered on deep understanding of clinical device protocols (DICOM, HL7, IEC 60601 standards), the ability to map device-to-clinical-workflow relationships, and clinical context awareness that generic IoT security platforms fundamentally lack. Purpose-built healthcare security is essential because generic approaches often produce false positives or block legitimate clinical operations, unacceptable in environments where device availability directly impacts patient safety.

Commercially, Medigate competed in the healthcare IoT security market alongside Claroty (which became its acquirer), Cynerio, Armis, Forescout/CyberMDX, and others. The company raised approximately $75M from investors including YL Ventures, U.S. Venture Partners, and Coatue Management, and built a significant customer base among large hospital systems. In 2022, Medigate merged with Claroty, creating a combined entity that brought Medigate's deep healthcare specialization to Claroty's broader OT/IoT security platform and expanding Claroty's addressable market within healthcare. The merger reflected the importance of healthcare to the broader industrial cybersecurity landscape and consolidated Israeli cybersecurity talent in the medical device security space.

From a defense and national-security perspective, medical device security directly applies to military healthcare infrastructure protection—including military hospitals, field hospitals, Veterans Affairs facilities, and military medical operations. Connected medical devices in defense healthcare environments represent high-value attack surfaces for adversaries seeking to disrupt military medical readiness during conflicts or crises. A compromised network could affect diagnostic accuracy, device functionality, or data integrity, potentially degrading healthcare delivery to service members. The underlying platform capabilities—device discovery, network segmentation, anomaly detection, protocol-level monitoring—transfer directly to military IoT/OT environments. Adaptation would be required for military-specific device standards, compliance requirements (DIACAP/RMF), and integration with defense cybersecurity architectures, but the core technology is applicable.

However, Medigate's dual-use relevance should be calibrated carefully: it is specialized healthcare security, not a general-purpose defense technology platform. The company's primary value has always been clinical healthcare, not defense applications. Any military use would require substantial customization and integration work beyond the core platform, and defense markets are not typically where healthcare-focused startups develop their primary traction. As part of Claroty (now a significant player in OT/ICS security), Medigate technology is consolidated into a broader portfolio that serves industrial and critical infrastructure sectors, including potential defense and national security applications through Claroty's broader OT security offerings.